얼굴용 주사제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Facial Injectable Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End-use, By Region & Competition, 2020-2030F
상품코드:1748733
리서치사:TechSci Research
발행일:2025년 06월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 얼굴용 주사제 시장은 2024년에 102억 2,000만 달러로 평가되며, 2030년까지 CAGR 8.22%로 성장할 것으로 예측됩니다.
더말 필러로도 알려진 안면 필러는 주로 미용적인 얼굴 회춘을 위해 사용되며, 주름과 볼륨 감소와 같은 노화의 초기 징후를 치료하는 데 사용됩니다. 미용에 대한 인식이 높아지고 합성 칼슘 하이드록실아파타이트 필러와 같은 주사제제의 발전과 함께 최소 침습적 미용 시술에 대한 수요가 증가하면서 시장 성장을 크게 촉진하고 있습니다. 주름 완화제 및 필러와 같은 비수술적 시술의 눈에 띄는 증가는 편리하고 위험이 낮은 치료로의 전환을 반영합니다. 또한 전 세계 인구의 고령화와 소셜미디어 동향에 힘입어 미용 증진에 대한 인기가 높아지면서 수요가 지속적으로 증가하고 있습니다. 규제 당국의 감시와 피부 반응과 같은 잠재적 부작용이 제약 요인으로 작용하는 반면, 비용 효율적이고 안전한 주사 솔루션의 혁신은 세계 시장 보급을 계속 촉진하고 있습니다.
The Global Facial Injectable Market was valued at USD 10.22 billion in 2024 and is projected to grow at a CAGR of 8.22% through 2030. Facial injectables, also known as dermal fillers, are primarily used for aesthetic facial rejuvenation, addressing early signs of aging such as wrinkles and volume loss. The increasing demand for minimally invasive cosmetic procedures, along with growing beauty consciousness and advancements in injectable formulations like synthetic calcium hydroxylapatite fillers, is significantly driving market growth. A notable rise in non-surgical procedures-such as wrinkle relaxers and fillers-reflects a shift toward convenient, low-risk treatments. Furthermore, the aging global population and rising popularity of cosmetic enhancements supported by social media trends continue to fuel demand. While regulatory scrutiny and potential side effects like skin reactions present limitations, innovations in cost-effective and safe injectable solutions continue to propel market adoption worldwide.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 10.22 Billion
Market Size 2030
USD 16.29 Billion
CAGR 2025-2030
8.22%
Fastest Growing Segment
Facial Line Correction
Largest Market
North America
Key Market Drivers
Rising Beauty Consciousness
The surge in beauty consciousness is a key factor driving the Global Facial Injectable Market. Increasingly, individuals are seeking non-invasive and minimally invasive solutions to maintain youthful appearances, improve facial aesthetics, and enhance self-confidence. For example, according to Botox Statistics 2025, over 4.7 million botulinum toxin type A procedures were performed in 2024-2025, showcasing strong consumer interest. A 6% year-over-year rise in such procedures, as reported by the American Society of Plastic Surgeons (ASPS), further underlines this upward trend. Facial injectables offer noticeable results with minimal downtime, making them preferred alternatives to surgical procedures like facelifts. The influence of celebrities and social media influencers also contributes to heightened demand, as users are exposed to cosmetic treatments and outcomes through various platforms. This cultural shift has spurred growth in medical spas and aesthetic clinics offering facial injectables. In parallel, increased educational outreach about the safety, benefits, and types of injectables has empowered consumers to make informed decisions, reinforcing the sustained rise in treatment adoption.
Key Market Challenges
Market Competition
Intense market competition presents a major challenge in the facial injectable space. The proliferation of global and regional manufacturers has led to price competition, compressing profit margins and making it difficult for companies to allocate budgets toward innovation and quality enhancements. When products are perceived as interchangeable, manufacturers face difficulties in differentiating their offerings, often resulting in commoditization. The pressure to cut costs can compromise product quality and safety, potentially diminishing consumer trust. Additionally, a saturated market may confuse potential clients and slow decision-making. This environment makes it challenging for businesses to foster long-term brand loyalty, especially as consumers frequently switch providers for better pricing or promotional offers. For smaller players, penetrating a crowded marketplace with limited marketing budgets further complicates growth. Sustained innovation, strategic branding, and quality assurance are crucial for standing out in this highly competitive sector.
Key Market Trends
Combination Treatments
The increasing popularity of combination treatments is reshaping the Global Facial Injectable Market. These treatments address multiple aesthetic concerns in a single session-such as wrinkles, facial volume loss, and uneven skin texture-offering patients comprehensive rejuvenation with more noticeable results. The appeal lies in personalized treatment plans tailored to individual facial anatomy and cosmetic goals, resulting in higher satisfaction rates and better clinical outcomes. Healthcare professionals are now combining different injectable types, often from the same product line, to optimize results while enhancing patient loyalty and cross-selling opportunities. This integrated approach also strengthens provider networks, encouraging collaboration among dermatologists, plastic surgeons, and aesthetic specialists. As demand for holistic, efficient, and customized facial rejuvenation continues to grow, combination treatments are becoming a strategic driver of patient retention and market revenue.
Key Market Players
Allergan plc.
Ipsen Inc.
Merz Pharma GmbH & Co. KGaA.
Suneva Medical, Inc.
Sinclair Pharma.
Bloomage Biotechnology Corp Ltd.
Anika Therapeutics, Inc.
Prollenium Medical Technologies Inc.
Galderma S.A.
Medytox
Report Scope:
In this report, the Global Facial Injectable Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Facial Injectable Market, By Product:
Collagen & PMMA Microspheres
Hyaluronic Acid (HA)
Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Poly-L-Lactic Acid (PLLA)
Others
Facial Injectable Market, By Application:
Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Others
Facial Injectable Market, By End Use:
MedSpa
Dermatology Clinics
Hospitals
Facial Injectable Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Facial Injectable Market.
Available Customizations:
Global Facial Injectable Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Facial Injectable Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Others)
5.2.2. By Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Others)
5.2.3. By End-use (MedSpa, Dermatology Clinics, Hospitals)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2024)
5.3. Market Map
6. North America Facial Injectable Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Others)
6.2.2. By Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Others)
6.2.3. By End-use (MedSpa, Dermatology Clinics, Hospitals)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Facial Injectable Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By End-Use
6.3.2. Canada Facial Injectable Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By End-Use
6.3.3. Mexico Facial Injectable Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By End-Use
7. Europe Facial Injectable Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Others)
7.2.2. By Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Others)
7.2.3. By End-use (MedSpa, Dermatology Clinics, Hospitals)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Facial Injectable Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By End-Use
7.3.2. Germany Facial Injectable Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By End-Use
7.3.3. United Kingdom Facial Injectable Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By End-Use
7.3.4. Italy Facial Injectable Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By End-Use
7.3.5. Spain Facial Injectable Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By End-Use
8. Asia-Pacific Facial Injectable Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Others)
8.2.2. By Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Others)
8.2.3. By End-use (MedSpa, Dermatology Clinics, Hospitals)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Facial Injectable Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By End-Use
8.3.2. India Facial Injectable Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By End-Use
8.3.3. Japan Facial Injectable Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By End-Use
8.3.4. South Korea Facial Injectable Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By End-Use
8.3.5. Australia Facial Injectable Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By End-Use
9. South America Facial Injectable Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Others)
9.2.2. By Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Others)
9.2.3. By End-use (MedSpa, Dermatology Clinics, Hospitals)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Facial Injectable Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By End-Use
9.3.2. Argentina Facial Injectable Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By End-Use
9.3.3. Colombia Facial Injectable Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By End-Use
10. Middle East and Africa Facial Injectable Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Collagen & PMMA Microspheres, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Poly-L-Lactic Acid (PLLA), Others)
10.2.2. By Application (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lipoatrophy Treatment, Others)
10.2.3. By End-use (MedSpa, Dermatology Clinics, Hospitals)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Facial Injectable Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By End-Use
10.3.2. Saudi Arabia Facial Injectable Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By End-Use
10.3.3. UAE Facial Injectable Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By End-Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Facial Injectable Market: SWOT Analysis
